Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
Lack of information about multiple sclerosis in children can impact parents' sense of competency and satisfaction within the couple.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
Correction: The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Disease-specific molecular events in cortical multiple sclerosis lesions.
Infectious mononucleosis.
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Is metabolic flexibility altered in multiple sclerosis patients?
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Pages
« first
‹ previous
…
311
312
313
314
315
316
317
318
319
…
next ›
last »